Abstract: The present disclosure provides antibodies and antigen-binding fragments that target transferrin receptor. Also provided is the use of these antibodies and antigen-binding fragments as carriers to deliver therapeutic molecules across the blood-brain barrier.
| # | Name | Date |
|---|---|---|
| 1 | 202517062811-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [01-07-2025(online)].pdf | 2025-07-01 |
| 2 | 202517062811-STATEMENT OF UNDERTAKING (FORM 3) [01-07-2025(online)].pdf | 2025-07-01 |
| 4 | 202517062811-Sequence Listing in PDF [01-07-2025(online)].pdf | 2025-07-01 |
| 5 | 202517062811-REQUEST FOR EXAMINATION (FORM-18) [01-07-2025(online)].pdf | 2025-07-01 |
| 6 | 202517062811-FORM 18 [01-07-2025(online)].pdf | 2025-07-01 |
| 7 | 202517062811-FORM 1 [01-07-2025(online)].pdf | 2025-07-01 |
| 8 | 202517062811-DRAWINGS [01-07-2025(online)].pdf | 2025-07-01 |
| 9 | 202517062811-DECLARATION OF INVENTORSHIP (FORM 5) [01-07-2025(online)].pdf | 2025-07-01 |
| 10 | 202517062811-COMPLETE SPECIFICATION [01-07-2025(online)].pdf | 2025-07-01 |
| 11 | 202517062811-RELEVANT DOCUMENTS [14-07-2025(online)].pdf | 2025-07-14 |
| 12 | 202517062811-MARKED COPIES OF AMENDEMENTS [14-07-2025(online)].pdf | 2025-07-14 |
| 13 | 202517062811-FORM 13 [14-07-2025(online)].pdf | 2025-07-14 |
| 14 | 202517062811-AMMENDED DOCUMENTS [14-07-2025(online)].pdf | 2025-07-14 |
| 15 | 202517062811-FORM-26 [04-08-2025(online)].pdf | 2025-08-04 |
| 16 | 202517062811-Proof of Right [01-10-2025(online)].pdf | 2025-10-01 |
| 17 | 202517062811-FORM 3 [01-10-2025(online)].pdf | 2025-10-01 |